Clinical trial · Interventional
Prehabilitation and Rehabilitation for Patients With Oesophageal Cancer
NCT04894149CI-TRIAL-00051925PRESOunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients with oesophageal cancer selected for oncological and surgical treatment with curative intent are offered supervised physiotherapy and home-based training before and after surgery.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Physiotherapy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Physiotherapy
- interventionNames
- Other: Physiotherapy
Primary outcomes (2)
- measure
- Adherence to exercise sessions.
- timeFrame
- Up to 40 weeks
- description
- Percentage of sessions completed out of number of sessions planned
- measure
- Un-planned interruptions in the prehabilitation/rehabilitation programme
- timeFrame
- Up to 40 weeks
- description
- Percentage of patients having an unplanned interruption of ten days or more of the supervised prehabilitation/rehabilitation programme
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histopathologically confirmed squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma in the oesophagus or cardia (Siewert I or II), cT1 N+ or cT2-4a any N, M0, according to the 8th version of the AJCC TNM classification. * Assessed at a multidisciplinary conference to be suitable for curatively intended oncological and surgical treatment. * Age \> 18 years. * Performance status ECOG 0-2. * Patient has provided written informed consent. Exclusion Criteria: * Previous radiotherapy in the thorax (except for tangential field radiotherapy for breast cancer). * Inability to understand written and spoken instructions and to comply with protocol requirements.
References
Publications (0)
Data not yet available
No reference posted for this study.